Kit S. Lam, M.D., Ph.D.
Professor and Chair
Oak Park Research Building, Sacramento Campus
For more information, visit the Kit Lam Laboratory website.
Dr. Lam is an expert in combinatorial chemistry, chemical biology, drug development, molecular imaging, nanotheranostics and medical oncology. His laboratory is engaged in the development and application of combinatorial library methods for basic research and drug discovery. In addition to cancer drug development and drug delivery, he is also interested in exosomes, membrane active peptides, signal transduction, antibiotics development, molecular immunology, chemical microarray, and proteomics. Dr. Lam is both a board-certified medical oncologist and a laboratory investigator. He is distinguished for revolutionizing cancer diagnosis and treatment and is acclaimed for his pioneering role in the field of combinatorial chemistry and developing the novel one-bead-one-compound technology, which rapidly screens millions of chemicals at one time to identify those that bind to diseased cells. The tool is advancing the early detection and precise delivery of treatments for brain, breast, prostate, pancreatic, lymphoma and other cancers. In addition, it is advancing the discovery of imaging agents that produce highly detailed molecular profiles of diseases for improved diagnosis and tracking medication effectiveness. His development and applications of combinatorial chemistry and other chemical methods look to solve many biomedical problems. Dr. Lam invented the “one-bead-one-compound” (OBOC) combinatorial library method, filed the patents (the basic patents on the OBOC technology was issued in 1996, 1997, and 1999 by the US patent office), and published the technique in Nature in 1991. The OBOC combinatorial library approach is unique and truly an ultra-high throughput method, as thousands to millions of chemical compounds (peptides, peptidomimetics, small molecules, nucleic acids, and macrocyclic natural product like molecules) can be efficiently synthesized and screened in parallel in a relatively short time.
In addition to expanding the use of one-bead-one-compound technology, Dr. Lam's research also includes developing a blood test for ovarian-cancer detection, utilizing nanoparticle carriers for drug delivery and synthesizing cancer-fighting molecules with less-toxic side effects. He is currently collaborating with faculty from the Veterinarian School of Medicine on translating nanotherapeutic and nano-imaging agents in canine and feline patients.
Wang XS, Kong DJ, Lin TY, Izumiya Y, Ding XZ, Zhang L, Hu XC, Yang JQ, Gao SG, Lam KS, and Li YP. A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer. Acta Pharmacol Sin. 38(6): 931-942, 2017.
Xiao K, Lin T, Lam KS, and Li YP. A facile strategy for fine-tuning the stability and drug release of stimuli-responsive cross-linked micellar nanoparticles towards precision drug delivery. Nanoscale, in press, 2017.
Tang Y, Thillier Y, Liu R, Li X, Lam KS, Gao T. Single-bead quantification of peptide loading distribution for One-Bead One-Compound library synthesis using confocal Raman spectroscopy. Analytical Chemistry, in press, 2017.
Carney RP, Thillier Y, Kiss Z, Sahabi A, Heleno Campos JC, Knudson A, Liu R, Olivos D, Saunders M, Tian L, Lam KS. Combinatorial library screening with liposomes for discovery of membrane active peptides. ACS Comb Sci. 19(5): 299-307, 2017.
Jian C, Tu MJ, Ho PY, Duan Z, Zhang Q, Qiu JX, deVere White RW, Wun T, Lara PN, Lam KS, Yu AX, Yu AM. Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models. Oncotarget. 8(19):30742-30755, 2017.
Shih TC, Liu R., Fung G, Bhardwaj G, Ghosh PM, Lam KS. A novel galectin-1 inhibitor discovered through one-bead-two-compounds library potentiates the anti-tumor effects of paclitaxel in vivo. Mol Cancer Ther, in press, 2017.
Bustos-Villalobos I, Bergstrom JW, Haigh NE, Luna JI, Marusina AI, Merleev AA, Wang EA, Sukhov A, Sultani H, Liu R, Bhardwaj G, Guo W, Kung HJ, Lam KS, W, Maverakis E. ITK inhibition for the targeted treatment of CTCL. J Dermatol Sci. Apr 3, 2017.
Liu R, Li X, Lam KS. Combinatorial chemistry in drug discovery. Curr Opin Chem Biol 38:117-126, 2017.
Mori S, Hatori N, Kawaguchi N, Hamada Y, Shih TC, Wu CY, Lam KS, Matsuura N, Yamamoto H, Takada YK, Takada Y. The integrin-binding defective FGF2 mutants potently suppress FGF2 signaling and angiogenesis. Bioscience Reports, in press, 2017.
Bharadwaj G, Nhan V, Yang S, LiX, Narayanan A, Macarenco AC, Shi Y, Yang D, Vieira LS, Xiao W, Li Y, Lam KS. Cholic Acid Based Novel Micellar Nano-platform for Delivering FDA Approved Taxanes. Nanomedicine 12(10):1153-1164, 2017.
Carney R, Hazari S, Colquhoun M, Tran D, Hwang B, Mulligan M, Bryers J, Girda E, Leiserowitz G, Smith Z, Lam KS. Multispectral optical tweezers for biochemical fingerprinting of CD9-positive exosome subpopulations. Analytical Chemistry, in press, 2017.
Carney R, Hazari H, Rojalin T, Knudson A, Gao T, Tang Y, Liu R, Viitala T, Yliperttula M, and Lam K S. Targeting Tumor-Associated Exosomes with Integrin-Binding Peptides. Advanced Biosystems, in press, 2017.
Hao D, Xiao W, Liu R, Kumar P, Li Y, Zhou P, Guo F, Farmer DL, Lam KS, Wang F, Wang A. Discovery and Characterization of a Potent and Specific Peptide Ligand Targeting Endothelial Progenitor Cells and Endothelial Cells for Tissue Regeneration. ACS Chem, 12(4):1075-1086, 2017.
Orbay H, Li Y, Xiao W, Cherry SR, Lam K, Sahar DE. Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model. Plast Reconstr Surg, 138:410-7, 2016.
Yao W, Lay Y, Kot A, Liu R, Zhang H, Chen H, Lam K, and Lane N. Improved mobilization of exogenous mesenchymal stem cells to bone for fracture healing and sex difference. Stem Cells. 34: 2587-2600, 2016.
Pan A, Zhang H, Li Y, Lin TY, Wang F, Lee J, Cheng M, Dall’Era M, Li T, deVere White R, Pan CX, Lam KS. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology. 27(42): 425103, 2016.
Lin TY, Li Y, Liu Q, Chen JL, Zhang H, Lac D, Zhang H, Ferrara KW, Wachsmann, Hogiu S, Li T, Airhart S, deVere White R, Lam KS, Pan C. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer. Biomaterials 104-339-351, 2016.
Lin TY, Guo W, Long Q, Ma A, Liu Q, Zhang H, Huang Y, Chandrasekaran S, Pan C, Lam KS, and Li Y. HSP90 inhibitor encapsulated photo-theranostic nanoparticles for synergistic combination cancer therapy. Theranostics. 6:1324-1335 (2016).
Chen CC, Xing L, Stark M, Ou T, Holla P, Xiao K, Kamita SG, Hammock BD, Lam K, Cheng RH. Chemically activatable viral capsid functionalized for cancer targeting. Nanomedicine (London) 11:377-390 (2016).
Liu R, Li X, Xiao W and Lam KS. Tumor-targeting peptides from combinatorial libraries. Adv Drug Deliv Rev. 2016 PMID: 27210583
Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Zu J, Kung HJ, Evans RM, Xu Y, Chen HW. ROR-g drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nature Medicine. March 2016.
Wu C, Wang DH, Wang X, Dixon S, Meng L, Ahadi S, Enter D, Chen CY, Kato J, Leon L, Ramirez L, Maeda Y, Reis C, Ribeiro B, Weems B, Kung HJ, Lam, KS. Rapid Discovery of Functional Small Molecule Ligands against Proteomic Targets through Library-Against-Library Screening. ACS Combinatorial Sciences 18:320-329, 2016. PMID:27053324
Xiao W, Li T, Bononi FC, Lac D, Kekessie IA, Liu Y, Sanchez E, Mazloom A, Ma AH, Lin J, Tran J, Yang K, Lam KS, Liu R. Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors. EJNMMI Res. 6: 18, 2016. PMID: 26922417.
Lac D, Feng C, Bhardwah G, Le H, Tran J, Xing L, Fung G, Liu R, Cheng H, Lam KS. Covalent chemical ligation strategy for mono- and polyclonal immunoglobulins at their nucleotide binding sites. Bioconjugate chemistry 2015. PMID: 26630124.
Awasthi S, Izu L, Mao Z, Jian Z, Landas T, Lerner A, Shimkunas R, Woldeyesus RA, Bossuyt J, Wood BM, Chen YJ, Matthews DL, Lieu DK, Chiamvimonvat N, Lam KS, Chen-Izu Y, Chan JW. Multimodal SHG-2PF imaging of microdomain Ca2+-contraction coupling in live cardiac myocytes. Circ Res 2015. PMID: 26643875
Wang Y, Xiao W, Zhang Y, Meza L, Tseng H, Takada Y, Ames JB and Lam KS. Optimization of RGD containing cyclic peptides against αvβ3 integrin. Mol Cancer Therapeutics, Dec 30, 2015. PMID: 26719578
Smith ZJ, Lee C, Rojalin T, Carney RP, Hazari S, Knudson A, Lam K, Saari H, Ibanez EL, Vitala T, Laaksonen T, Yliperttula M, and Wachsmann-Hogiu S. Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content. Journal of Extracellular Vesicles. In press Nov 2015
Zhang P, Zam A, Jian Y, Wang X, Ki Y, Lam KS, Burns ME, Sarunic MV, Pugh EN and Zawadzki RJ. In vivo wide-field multispectral SLO-OCT mouse retinal imager: longitudinal imaging of ganglion cells, microglia and Müller glia, and mapping of the mouse retinal and choroidal vasculature, Journal of Biomedical Optics. 20: 126005, 2015. PMID 26677070
Leung NY, Wai CY, Ho MH, Liu R, Lam KS, Wang JJ, Shu SA, Chu KH, Leung PS. Screening and identification of mimotopes of the major shrimp allergen tropomyosin using one-bead-one-compound peptide libraries. Cell Mol Immunol. 2015 Sep 14. doi: 10.1038/cmi.2015.83. PMID 26364917
Ding Y, Li J, Xiao W, Xiao K, Lee JS, Bhardwaj U, Zhu Z, Digiglio P, Yang G, Lam KS, Pan T. Microfluidic-Enabled Print-to-Screen (P2S) Platform for High-Throughput Screening of Combinatorial Chemotherapy. Anal Chem. 87: 10166-71, 2015 . PMID 26334956.
Barisone GA, Satake N, Lewis C, Duong C, Chen C, Lam KS, Nolta J, Diaz E. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells. Blood Cells Mol Dis. 54(4):329-35, 2015. PMID: 25554682.
Xiao K, Li YP, Wang C, Ahmad S, Vu M, Kuma K, Cheng YQ, Lam KS. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer. Biomaterials. 67:183-93, 2015. PMID: 26218744.
Liu R, Shih TC, Deng X, Anwar L, Ahadi S, Kumaresan P, Lam KS. Design, synthesis, and application of OB2C combinatorial peptide and peptidomimetic libraries. Methods Mol Biol. 1248:3-22, 2015.
Wang WP, Ho PY, Chen QX, Addepalli B, Limbach PA, Li MM, Wu WJ, Jilek JL, Qiu JX, Zhang HJ, Li T, Wun T, White RD, Lam KS, Yu AM. Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization. J Pharmacol Exp Ther. 354(2):131-41, 2015.
Lee C, Carney RP, Hazari S, Smith Z, Knudson A, Robetson C, Lam KS, Wachsmann-Hogiu S. 3D plasmonic nanobowl platform for the study of exosomes in solution. Nanoscale, 7: 9290-9297, 2015. (PMID: 25939587).
Fujita M, Zhu K, Fujita CK, Zhao M, Lam KS, Kurth MJ, Takada YK, and Takada Y. Proinflammatory sPLA-IIA induces integrin activation through direct binding to a newly identified binding-site (site 2) in integrins α4β1, and α5β1. J Biol Chem 290: 259-71, 2014. (PMID 25398877).
Guo W, Liu R, Bhardwaj G, Yang J, Changou C, Ma AH, Mazloom A, Chintapalli S, Xiao K, Xiao W, Pappanaicken K, Sanzhez E, Yeh CT, Evans C, Patterson R, Lam K., Kung HJ. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor. Cell Death and Disease, in press, 2014.
Ngo T, Barisone GA, Lam KS, Diaz E. MXD3 regulation of DAOY cell profileration dictated by time course of activation. BMC Cell Bio. 15: 30 ( July 23 2014). (PMID 25053245)
Li Y, Lin T, Luo Y, Liu Q, Xiao W, Guo W, Lac D, Zhang H, Feng C, Wachsmann-Hogiu S, Walton JH, Cherry SR, Rowland DJ, Kukis D, Pan C, and Lam KS. A Smart and Super Versatile "All-in-One" Theranostic Nanomedicine Platform. Nature Communication, 5: 4712, 2014. (PMID 25158161)
Shi C, Yuan D, Nangia S, Xu G, Lam K, Luo J. A Structure-Property Relationship Study of the Well-defined Telodendrimers to improve hemocompatibility of nanocarriers for anticancer drug delivery. Langmuir, 30: 6878-6888, 2014. (PMID 24849780)
Zhang H, Li Y, Lin TY, Xiao K, Haddad AS, Henderson PT, Jonas BA, Chen M, Xiao W, Liu R, Lam KS, and Pan CX. Nanomicelle formulation modified the pharmacokinetic profiles and cardiac toxicity of daunorubicin. Nanomedicine (Lond). 2014 Mar 17. (PMID 24628688).
Jian Z, Han H, Zhang T, Puglisi JH, Izu L, Shaw JA, Onofiol E, Erickson JR, Chen Y, Horvath B, Shimkunas R, Xiao W, Li Y, Pan T, Chan J, Banyasz T, Tardiff J, Chiamvimonvat N, Bers DM, Lam KS, Chen-Izu C. Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling. Science Signaling 317 (PMID 24643800)
Garland SP, Wang RY, Raghunathan VK, Lam KS, Murphy CJ, Russell P, Sun G, Pan T. Photopatternable and photoactive hydrogel for on-demand generation of hydrogen peroxide in cell culture. Biomaterials. 35: 1762-1770. (PMID: 24290809)
Li Y, Xiao K, Zhu W, Deng W, Lam KS. Stimuli-response cross-linked micelles for on-demand dr7g delivery against cancers. Adv Drug Deliv Rev. 66c: 58-73, 2014. (PMID 24060922).
Hua S, Saunders M, Dimapasoc L, Jeong SH, Kim S, So M, Lee KS, Jae H, Lam KS, Lebrilla C, An HJ. Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling. Journal of Proteome Research, 13: 961-968, 2014. (PMID 24303873)
Sun YS, Luo J, Lam KS, Zhu XD. Detection of formation and disintegration of micelles by oblique-incidence reflectivity difference microscopy. Instrument Science and Technology. 41: 545-555, 2013.
Xiao K, Suby N, Li Y, and Lam KS. Telodendrimer-based nanocarriers for the treatment of ovarian cancer. Therapeutic Delivery. In press, October 2013.
Kenyon NJ, Bratt JM, Lee J, Luo J, Franzi LM, Zeki AA, and Lam KS. Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airway inflammation. PLOS ONE, in press, 2013.
Jialal I, Devaraj S, Smith G, Lam K, Kumaresan P. A novel peptide inhibitor attenuates C-reactive protein’s pro-inflammatory effects in vivo. International Journal of Cardiology, in press, 2013.
Guo W, Liu R, Bhardwaj G, Ma A, Changou C, Yang JC, Li Y, Feng C,Luo Y, Mazloom A, Sanchez E, Wang Y, Huang W, Patterson R, Evans CP, Lam KS, Kung H. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostrate cancer cells and overcomes resistance to Src inhibitors. PLOS ONE, in press, 2013.
Yao W, Guan M, Jia J, Dai W, Lay YE, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, and Lane NE. Reversing bone loss by directing mesenchymal stem cells to the bone. Stem Cells. In press, 2013.
He W, Luo J, Bourguet F, Xing L, Yi SK, Gao T, Blanchetter C, Henderson PT, Kuhn E, Malfatti M, Murphy WJ, Cheng RH, Lam KS, Coleman MA. Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry. Protein Sci. 2013.
Huang W, Shi C, Shao Y, Lam KS, and Luo J. The core-inversible micelles for hydrophilic drug delivery. Chem Commun (Camb), 49: 6674-6676, 2013.
Ding Y, Huang E, Lam KS, and Pan T. Microfluidic impact printer with interchangeable cartridges for versatile non-contact multiplexed micropatterning. Lab Chip, 13: 1902-1910, 2013.
Xiao W, Bononi FC, Townsend J, Li Y, Liu R, Lam KS. Immobilized OBOC combinatorial bead array to facilitate multiplicative screening. Comb Chem High Throughput Screen. 16: 441-448, 2013.
Malekan H, Fung G, Thon V, Khedri Z, Yu H, Qu J, Li Y, Ding L, Lam KS, Chen X. One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid. Bioorganic and Medicinal Chemistry. 2013.
Leung PS, Wang J, Naiyanetr P, Kenny TP, Lam KS, Kurth MJ, and Gershwin ME. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun. 41: 79-86, 2013.
Kumaresan P, Devaraj S, Huang W, Lau E, Liu R, Lam KS, and Jialal I. Synthesis and Characterization of a Novel Inhibitor of CRP-mediated Pro-Inflammatory Effects. Metabolic Syndrome and Related Disorders. 11: 177-184, 2013.
Yang F, Liu R, Kramer R, Xiao W, Jordan R, Lam KS. Discovery of specific ligands for oral squamous carcinoma to develop anti-cancer drug loaded precise targeting nanotherapeutics. J Calif Dent Assoc, 40: 939-943, 2013.
Ye L, Dickerson T, Kaur H, Takada YK, Fujita M, Liu R, Knapp JM, Lam KS, Schore NE, Kurth MJ, Takada Y. Identificaiton of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3. Bioorganic & Medicinal Chemistry Letters. 23: 350-345, 2012.
Duru N, FanM, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A,Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ. HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells. Clin Cancer Res. 18:6634-6647, 2012.
Li YP, Budamagunta M, Luo J, Xiao W, Voss J, and Lam KS. Probing of the Assembly Structure and Dynamics within Nanoparticles during Interaction with Blood Proteins. ACS Nano, 6:9485-9489, 2012.
Lee J, and Lam KS. Perspectives on Clinical Translation of Smart Nanotherapeutics. Therapeutic Delivery: Special issue on "Intelligent Drug Design" 3: 1359-1362, 2012.
Lin T, Li Y, Zhang H, Luo J, Good win N, Gao T, deVere White R, Lam KS, Pan CX. Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Nanomedicine, 2012, in press.
Wu M, Piccini M, Koh CY, Lam KS, Singh AK. Single cell microRNA analysis using microfluidic flow cytometry. PLOS One, 2012, in press.
Leung PS, Lam K, Kurth MJ, Coppel RL, Gerhswin ME. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Trends Mol Med. 18: 577-582, 2012.
Guo W, Liu R, Ono Y, Ma AH, Martinez A, Sanchez E, Wang Y, Huang W, Mazloom A, Li J, Ning J, Maverakis E, Lam KS, Kung HJ. Molecular characteristics of CTA056, a novel Itk inhibitor which selectively targets malignant T cells and modulates oncomirs. Mol Pharmacol. 82: 938-47, 2012 (PMID: 228998868).
Shaheen F, Rizvi TS, Musharraf SG, Ganesan A, Xiao K, Townsend JB, Lam KS, Choudhary MI. Solid-phase total synthesis of cherimolacyclopeptide E and discovery of more potent analogues by alanine screening. J Nat Prod. Nov 13, 2012.
Lin TY, Zhang H, Luo J, LiY, Gao T, Lara PN Jr, deVere White R, Lam KS, Pan CX. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Int J Nanomedicine. 7:2793-2804, 2012.
Hu X, Kheirolomoom A, Mahakian LM, Beegle JR, Kruse DE, Lam KS, Ferrara KW. Insonation of targeted microbubbles produces regions of reduced blood flow within tumor vasculature. Invest Radiol. 47: 398-405, 2012.
Kato J, Li Y, Xiao K, Lee J, Luo J, Tuscano J, O’Donnell R, Lam KS. Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma. Molecular Pharmaceutics. 9: 1727-1735, 2012. (PMID: 22530955)
Zwingenberger AL, Kent MS, Liu R, Kukis DL, Wisner ER, DeNardo SJ, Taylor SL, and Lam KS. In vivo biodistribution and safety of 99mTc-LLP2A-Hynic in canine non-Hodgkin’s lymphoma. PLos One, 7(4):e34404, 2012.
Zwingenberger AL, Kent MS, Shi C, Taylor SL, Chen X, and Lam KS. Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma. Veterinary Immunology and Immunopathology. 145: 298-304, 2012. (PMDI: 22177114)
Xiao K, Li Y, Lee JS, Gonik AM, Dong T, Fung G, Sanchez E, Xing L, Cheng HR, Luo J, and Lam KS. "OA02" Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo. Cancer Research. 72(8): 2100-2110, 2012. (PMID: 22396491)
Skokeen M, Zheleznyak A, Wilson JM, Jiang M, Liu R, Ferdani R, Lam KS, Schwarz, Anderson CJ. Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche. The Journal of Nuclear Medicine, 53: 779-786, 2012. (PMDI 22496586)
Zhang H, Luo J, Li Y, Henderson PT, Wang Y, Wachsmann-Hogiu S, Zhao W, Lam KS, Pan C. Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells. Nanomedicine: Nanotechnology, Biology, and Medicine. In press, 2012. (PMDI: 22197725)
Xiao W, Luo J, Jian T, Riggs J, Tseng H, Henderson PT, Cherry S, Rowland D, and Lam KS. The biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nano-formulation in an ovarian cancer mouse xenograft model. International Journal of Nanomedicine. 7: 1587-1597, 2012.
Li Y, Xiao W, Xiao K, Berti L, Luo J, Tseng HP, Gung G, and Lam KS. Well-Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to acidic pH and cis-Diols. Angewandte Chemie Int Ed Engl. 51: 2864-2869, 2012. (PMID: 22253091)
Lin T, Zhang H, Luo J, Li Y, Gao T, Lara PN, de Vere White R, Lam KS, and Pan CX. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. International Journal of Nanomedicine. 7: 2793-2804, 2012.
Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Ranganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, and Lane NE. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nature Medicine. 18: 456-462, 2012. (PMID: 22306732)
Aina OH, Maeda Y, Harison M, Zwingenberger AL, Walker NJ, Lam KS, and Kent MS. Canine malignant melanoma alpha-3 integrin binding peptides. Vet immunol immunopathol. 143:11-19, 2011. (PMID: 21722969)
Naiyanetr P, Butler JD, Meng L, Pfeiff J, Kenny TP, Guggenheim KG, Reiger R, Lam KS, Kurth MJ, Ansari AA, Coppel RL, Lopez-Hoyos M, Gershwin ME, Leujng PSC. Electrophile-Modified Lipoic Derivatives of PDC-E2 Elicits Anti-mitochondrial Antibody Reactivity. Journal of Autoimmunity. 37:209-216, 2011.
Yao N, Chen CY, Wu CY, Motonishi K, Kung HJ, Lam KS. Novel flavonoids with anti-proliferative activities against breast cancer cells. J of Medicinal Chemistry, 54: 4339-4349, 2011.
Xiao K, Luo J, Li Y, Lee JS, Fung G, Lam KS. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. Journal of Controlled Release. 155: 272-281, 2011.
Li Y, Xiao K, Luo J, Xiao W, Lee JS, Gonik AM, Kato J, Dong T, and Lam KS. Well-defined, Reversible Disulfide Cross-linked Micelles for On-demand Paclitaxel Delivery. Biomaterial. 32: 6633-6645, 2011.
Shi L, Fleming CJ, Riechers SL, Yin NN, Luo J, Lam KS, Liu GY. High-Resolution Imaging of Dendrimers Used in Drug Delivery via Scanning Probe Microscopy. Journal of Drug Delivery. Jun13. 2011.
Kawano M, Xing L, Hand H, Miyamura T, Barnett S, Srivastava I, Lam KS, Cheng H. Design platforms of nanocapsules for human therapeutics or vaccines. In Development of Vaccines, from discovery to clinical testing, ed Singh M and Srivastava I. Wiley, pp125-140, 2011, 2011.
Chang PC, Fitzgerald LD, Hsia DA, Izumiya Y, Wu CY, Hsieh WP, Lin SF, Campbell M, Lam KS, Luciw PA, Tepper CG, Kung HJ. Histone demethylase JMJD2A regulates KSHV replication and is targeted by a viral transcriptional factor. J Virol. 85: 3283-3293, 2011.
Ding Y, Hong L, Nie B, Lam KS, Pan T. Capillary-driven automatic packaging. Lab on a Chip. 11: 1464-1469, 2011.
Xiao K, Li Y, Luo J, Lee JS, Xiao W, Gonik AM, Agarwal RG, Lam KS. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 32: 3435-3446, 2011.
Kumaresan P, Wang Y, Saunders M, Maeda Y, Wang X, Liu R, Lam KS. Rapid Discovery of Death Ligands with One-Bead-Two-Compound Combinatorial Library Methods. Journal of Combinatorial Sciences. 13: 259-264, 2011.
Li J, Liu R, Lam KS, Jin LW, Duan Y. Alzheimer’s disease drug candidates stabilize A-beta protein native structure by interacting with the hydrophobic core. Biophysical Journal. 100: 1076-1082, 2011.
Upper division courses
- 192 Internship in Biological Chemistry
- 198 Group Study
- 199 Special Study for Advanced Undergraduates
- 298 Group Study
- 299 Research
Professional courses for medical students
- 410A Molecular and Cell Biology
- 410B Cell Biology and Metabolism
- 414 Molecular Medicine
- 491 Human Genetics Seminar
- 497 Tutoring in Biological Chemistry
- 498 Group Study
- 499 Research
- 2008 Fellow of American College of Physicians
- 2009 “Above and Beyond Mentor Award” from the Center for Biophotonics Science and Technology at UC Davis
- 2010 Harold Albin Johnson endowed Chair in Biomedical Research.
- National Institutes of Health
- Department of Defense